V. Bosch

发表

Conformation‐specific Display of 4E10 and 2F5 Epitopes on Self‐assembling Protein Nanoparticles as a Potential HIV Vaccine

P. Burkhard, O. Keppler, Yongkun Yang, 2012, Chemical biology & drug design.

Complement activation by HIV-1-infected cells: the role of transmembrane glycoprotein gp41.

U. Krüger, M. Dierich, J. Patsch, 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

HIV pseudovirion vaccine exposing Env "fusion intermediates"-response to immunisation in human CD4/CCR5-transgenic rats.

T. Ebensen, C. Guzmán, O. Keppler, 2009, Vaccine.

Analysis of the exposure of induced HIV glycoprotein epitopes in a potential HIV pseudovirion vaccine.

O. Keppler, V. Bosch, G. Devitt, 2007, Vaccine.

Role of the C-terminal domain of the HIV-1 glycoprotein in cell-to-cell viral transmission between T lymphocytes

O. Fackler, T. Pfeiffer, V. Bosch, 2010, Retrovirology.

Mutational analysis of the human immunodeficiency virus type 1 env gene product proteolytic cleavage site

M. Pawlita, V. Bosch, 1990, Journal of virology.

Pseudotyping of murine leukemia virus with the envelope glycoproteins of HIV generates a retroviral vector with specificity of infection for CD4-expressing cells.

B. Groner, R. Kurth, K. Cichutek, 1997, Proceedings of the National Academy of Sciences of the United States of America.

Inhibition of cellular glycoprotein incorporation into human immunodeficiency virus-like particles by coexpression of additional cellular interaction partner.

V. Bosch, P. Henriksson, 1998, Virology.

Optimized protocol for the large scale production of HIV pseudovirions by transient transfection of HEK293T cells with linear fully deacylated polyethylenimine.

A. Klibanov, Mini Thomas, T. Pfeiffer, 2007, Journal of virological methods.

Analysis of vif-defective human immunodeficiency virus type 1 (HIV-1) virions synthesized in 'non-permissive' T lymphoid cells stably infected with selectable HIV-1.

T. Wilk, V. Bosch, C. Ochsenbauer, 1997, The Journal of general virology.

Glycoprotein incorporation and HIV-1 infectivity despite exchange of the gp160 membrane-spanning domain.

T. Wilk, T. Pfeiffer, V. Bosch, 1996, Virology.

cellular FLICE-inhibitory protein (c-FLIP) HTLV-1 tax protects against CD95-mediated apoptosis by induction of the

V. Bosch, A. Merling, S. Fas, 2013 .

HTLV-1 Tax protects against CD95-mediated apoptosis by induction of the cellular FLICE-inhibitory protein (c-FLIP).

P. Krammer, M. Li‐Weber, A. Krueger, 2006, Blood.

Effects of signal peptide exchange on HIV‐1 glycoprotein expression and viral infectivity in mammalian cells

T. Pfeiffer, V. Bosch, G. Devitt, 2006, FEBS letters.

Cell-free infectivity of HIV type 1 produced in nonpermissive cells is only moderately impacted by C-terminal Env truncation despite abrogation of viral spread.

T. Pfeiffer, V. Bosch, Denise Holtkotte, 2007, AIDS research and human retroviruses.

Generation of H9 T-cells stably expressing a membrane-bound form of the cytoplasmic tail of the Env-glycoprotein: lack of transcomplementation of defective HIV-1 virions encoding C-terminally truncated Env

T. Pfeiffer, V. Bosch, Denise Holtkotte, 2006, Retrovirology.

Selection and characterization of a replication-competent human immunodeficiency virus type 1 variant encoding C-terminally truncated env.

T. Pfeiffer, V. Bosch, Thorsten Pisch, 2006, AIDS research and human retroviruses.

HIV-1-induced cytopathogenicity in cell culture despite very decreased amounts of fusion-competent viral glycoprotein.

T. Pfeiffer, V. Bosch, 1992, AIDS research and human retroviruses.

Retained in vitro infectivity and cytopathogenicity of HIV-1 despite truncation of the C-terminal tail of the env gene product.

T. Wilk, T. Pfeiffer, V. Bosch, 1992, Virology.

Inter-retroviral fusion mediated by human immunodeficiency virus or murine leukemia virus glycoproteins: independence of cellular membranes and membrane vesicles.

T. Pfeiffer, V. Bosch, S. Sparacio, 2002, Virology.

Transfer of endoplasmic reticulum and Golgi retention signals to human immunodeficiency virus type 1 gp160 inhibits intracellular transport and proteolytic processing of viral glycoprotein but does not influence the cellular site of virus particle budding.

H. Zentgraf, T. Pfeiffer, V. Bosch, 1997, The Journal of general virology.

Differential expression of endogenous virus glycoprotein in fibroblasts and sera of some adult chickens.

V. Bosch, R. Friis, A. Gebhardt, 1983, The Journal of general virology.

Incorporation of chimeric HIV-SIV-Env and modified HIV-Env proteins into HIV pseudovirions.

T. Pfeiffer, V. Bosch, G. Devitt, 2007, Virology.

Incorporation of Wild-Type and C-Terminally Truncated Human Epidermal Growth Factor Receptor into Human Immunodeficiency Virus-Like Particles: Insight into the Processes Governing Glycoprotein Incorporation into Retroviral Particles

Hans-Georg Zentgraf, T. Pfeiffer, V. Bosch, 1999, Journal of Virology.

Polypeptides of endogenous avian C-type viruses: their detection in the plasma membrane of normal and infected cells.

R. Kurth, D. Bolognesi, V. Bosch, 1977, Virology.

Properties of Wild-Type, C-Terminally Truncated, and Chimeric Maedi-Visna Virus Glycoprotein and Putative Pseudotyping of Retroviral Vector Particles

V. Bosch, U. Zeilfelder, Udo Zeilfelder, 2001, Journal of Virology.

The detection of glycoproteins immunologically related to RSV gp85 in uninfected avian cells and in sera from uninfected birds.

R. Kurth, V. Bosch, J. Smart, 1978, Virology.

The duck hepatitis B virus P-gene codes for protein strongly associated with the 5'-end of the viral DNA minus strand.

R. Bartenschlager, G. Radziwill, H. Schaller, 1988, Virology.

The duck hepatitis B virus DNA polymerase is tightly associated with the viral core structure and unable to switch to an exogenous template.

H. Zentgraf, G. Radziwill, H. Schaller, 1988, Virology.

The potential of retroviral vectors to cotransfer human endogenous retroviruses (HERVs) from human packaging cell lines.

V. Bosch, O. Frank, W. Seifarth, 2007, Gene.

Inhibition of release of lentivirus particles with incorporated human influenza virus haemagglutinin by binding to sialic acid-containing cellular receptors.

D. Steinhauer, T. Pfeiffer, V. Bosch, 2001, The Journal of general virology.

Membrane fusion between retroviral particles: host-range extension and vaccine prospects.

T. Pfeiffer, V. Bosch, T. Henzler, 2000, Virology.

Generation of lymphocyte cell lines coexpressing CD4 and wild-type or mutant HIV type 1 glycoproteins: implications for HIV type 1 Env-induced cell lysis.

U. Krüger, T. Pfeiffer, V. Bosch, 1996, AIDS research and human retroviruses.

Analysis of protein expression and virus-like particle formation in mammalian cell lines stably expressing HIV-1 gag and env gene products with or without active HIV proteinase.

K. Mergener, H. Kräusslich, H. Gelderblom, 1993, Virology.

Generation of a flexible cell line with regulatable, high-level expression of HIV Gag/Pol particles capable of packaging HIV-derived vectors.

H. Schaal, T. Pfeiffer, V. Bosch, 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

Study of group-specific proteins in mammalian cells transformed by Rous sarcoma virus.

V. Bosch, H. Černá, V. Sovová, 1978, Folia biologica.

Identification of the Cellular Prohibitin 1/Prohibitin 2 Heterodimer as an Interaction Partner of the C-Terminal Cytoplasmic Domain of the HIV-1 Glycoprotein

M. Schnölzer, T. Kempf, T. Pfeiffer, 2009, Journal of Virology.

Mutational analysis of the internal membrane proximal domain of the HIV glycoprotein C-terminus.

M. Widera, H. Schaal, T. Pfeiffer, 2013, Virology.

Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gpl60

H. Klenk, E. Shaw, W. Garten, 1992, Nature.

An Intronic G Run within HIV-1 Intron 2 Is Critical for Splicing Regulation of vif mRNA

K. Köhrer, R. Deenen, D. Widera, 2012, Journal of Virology.

Detection and initial characterization of protein entities consisting of the HIV glycoprotein cytoplasmic C-terminal domain alone.

H. Schaal, T. Pfeiffer, V. Bosch, 2013, Virology.

Expression of biologically active HIV glycoproteins using a T7 RNA polymerase-based eucaryotic vector system

J. Dunn, H. Kräusslich, T. Wilk, 1992, Virus Genes.

Fully functional, naturally occurring and C-terminally truncated variant human immunodeficiency virus (HIV) Vif does not bind to HIV Gag but influences intermediate filament structure.

H. Spring, T. Pánek, H. Herrmann, 2001, The Journal of general virology.

Unimpaired function of a naturally occurring C terminally truncated vif gene product of human immunodeficiency virus type 1.

V. Bosch, U. Wieland, I. Oelze, 1996, The Journal of general virology.

Generation and characterization of a stable cell population releasing fluorescent HIV-1-based Virus Like Particles in an inducible way

O. Schwartz, F. Superti, A. Tinari, 2006, BMC biotechnology.

T. Pfeiffer, V. Bosch, Denise Holtkotte, 2006, Retrovirology.

C. Boschek, A. Ziemiecki, V. Bosch, 1981 .

HTLV-1 Tax protects against CD95-mediated apoptosis by induction of the cellular FLICE-inhibitory protein (c-FLIP).

P. Krammer, M. Li‐Weber, A. Krueger, 2006, Blood.

Mutational analysis of the internal membrane proximal domain of the HIV glycoprotein C-terminus.

M. Widera, H. Schaal, T. Pfeiffer, 2013, Virology.